Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 14/20 | 0.44 |
| ▸ | SRC | P12931 | 5/20 | 0.44 |
| ▸ | EGFR | P00533 | 3/20 | 0.44 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.44 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.44 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.44 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.41 |
| ▸ | KDR | P35968 | 2/20 | 0.41 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3965330 | 0.93 | SLC2A1 (0.43) | FGFR1SRCEGFRFGFR2FGFR4 | |
| SCHEMBL3971053 | 0.93 | SLC2A1 (0.43) | FGFR1SRCEGFRFGFR2FGFR4 | |
| SCHEMBL3971739 | 0.91 | VCP (0.46) | FGFR1SRCEGFRFGFR2FGFR4 | |
| SCHEMBL3969374 | 0.90 | LCK (0.41) | FGFR1SRCEGFRFGFR2FGFR4 | |
| SCHEMBL3966578 | 0.89 | FGFR1 (0.50) | FGFR1SRCEGFRFGFR2FGFR4 | |
| SCHEMBL3964127 | 0.89 | FGFR1 (0.44) | FGFR1SRCEGFRFGFR2FGFR4 | |
| SCHEMBL3970084 | 0.88 | FGFR1 (0.45) | FGFR1SRCEGFRFGFR2FGFR4 | |
| Hydrochloric Acid SCHEMBL3962134 | 0.87 | FGFR1 (0.40) | FGFR1SRCEGFRFGFR2FGFR4 | |
| SCHEMBL3965934 | 0.86 | FGFR1 (0.43) | FGFR1SRCEGFRFGFR2FGFR4 | |
| SCHEMBL3970200 | 0.85 | FGFR1 (0.44) | FGFR1SRCEGFRFGFR2FGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1989200-B1 | [4-(BENZO[B]THIOPHEN-2-YL)-PYRIMIDIN-2-YL]-AMINE DERIVATIVES AS IKK-BETA INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES | LILLY CO ELI (US) | 2009-07-29 | — | — | EP | disclosed |